[ad_1] Wiesbaden, Germany – The Seqirus Quadruple Influenza Cell (QIVc) has received a favorable opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) for people aged …
Read More »[ad_1] Wiesbaden, Germany – The Seqirus Quadruple Influenza Cell (QIVc) has received a favorable opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) for people aged …
Read More »